Opinion & analysis

Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules

On the same day the American Kratom Association published its own standards for safety, the FDA coincidentally released the contents of a warning letter to Avalon Packaging, Inc., a kratom contract manufacturer, citing concerns about the manufacturing process and salmonella contamination.

Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules

P&G Grooming Quits Counting Blades, Innovates In New Directions While Battling DTC Disruptors

Infant Formula Production Stalls On Reckitt Benckiser’s Latest Stumble

116th Congress Could Test Cosmetic Industry’s Commitment To Reg Reform, Preemption Viability

FDA Plans Consumer Survey To Better Understand Cosmetics Allergy Prevalence

Vanda Warning Letter From US FDA Leaves Firm “Puzzled”

US FDA May Largely Avoid House Democrats’ Investigation Agenda

Trump’s Drug Pricing ‘Dream Team’ And Prospects For Change

CAR-T Label Update Could Address Medicare Coverage Challenges, FDA’s Gottlieb Suggests

Keeping Up With “The Energizer Bunny”: US FDA Commissioner Gottlieb As A Boss

Infographic – 2018 Pharma Pipeline Snapshot

Pfizer’s Reference Point on Trial Innovation : Ask the Patient

GSK Woes Raise Big Pharma R&D Question

Data, AI And Machine Learning Are Propelling Clinical Trials Data Analysis To New Heights

State Of Pharma R&D: Ex-Takeda’s Yamada Takes The Long View